Applicant, as named in the Orange Book

Blueprint Medicines

Next listed expiry: Ayvakit on 10 Apr 2040. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Ayvakit NDA 212608 · 5 strengths avapritinib	avapritinib	10 Apr 2040 patent, carve-out possible	patent, carve-out possible

Ayvakit · Exclusivity expires within 90 days ODE-366Exclusivity expires 9 Jan 2027Detected 24 Oct 2026
Ayvakit · Exclusivity expires within 90 days ODE-366Exclusivity expires 9 Jan 2027Detected 24 Oct 2026
Ayvakit · Exclusivity expires within 90 days ODE-366Exclusivity expires 9 Jan 2027Detected 24 Oct 2026
Ayvakit · Exclusivity expires within 90 days ODE-366Exclusivity expires 9 Jan 2027Detected 24 Oct 2026
Ayvakit · Exclusivity expires within 90 days ODE-366Exclusivity expires 9 Jan 2027Detected 24 Oct 2026